AAAAAA
Results: 1-25/34
Authors:
ADDINGTON J
ADDINGTON D
Citation: J. Addington et D. Addington, VISUAL-ATTENTION AND SYMPTOMS IN SCHIZOPHRENIA - A 1-YEAR FOLLOW-UP, Schizophrenia research, 34(1-2), 1998, pp. 95-99
Authors:
ADDINGTON J
ADDINGTON D
Citation: J. Addington et D. Addington, FACIAL AFFECT RECOGNITION AND INFORMATION-PROCESSING IN SCHIZOPHRENIAAND BIPOLAR DISORDER, Schizophrenia research, 32(3), 1998, pp. 171-181
Authors:
ADDINGTON J
ADDINGTON D
Citation: J. Addington et D. Addington, NEUROCOGNITIVE FUNCTIONING IN FIRST EPISODE SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 50-51
Authors:
NAIR NPV
REINER C
REITERSCHMITT B
RONOVSKY K
VYSSOKI D
BAEKE J
DESSEILLES M
KINDTS P
MESOTTEN F
PEUSKENS J
ADDINGTON D
BARUCH P
BEAUCLAIR L
BLOOM D
BOUCHARD RH
FILTEAU M
JEFFRIES J
JONES B
LABELLE A
MAJOR B
NAIR N
POURCHER E
REMINGTON G
RIPLEY C
TOEWS J
VINCENT P
WOLF M
ZIPURSKY R
CHABANNES JM
COHEN C
DUPUY C
LAGHRISSITHODE F
LOMBERTIE E
LUNACEK S
PAGNON I
PUPESCHI G
VANAMERONGEN A
DEMLING J
EBERT D
HUMMEL MM
MAYER G
RETTERATH P
SEIFERT G
WENNHOLD B
ZINZTSCH I
DELZOMPO M
ARDON J
DRIES P
MEULDIJK R
JEPPESEN I
MAHNFELDT M
NERDRUM T
OSBY U
Citation: Npv. Nair et al., THERAPEUTIC EQUIVALENCE OF RISPERIDONE GIVEN ONCE-DAILY AND TWICE-DAILY IN PATIENTS WITH SCHIZOPHRENIA, Journal of clinical psychopharmacology, 18(2), 1998, pp. 103-110
Authors:
ADDINGTON D
ADDINGTON J
PATTEN S
Citation: D. Addington et al., DEPRESSION IN PEOPLE WITH FIRST-EPISODE SCHIZOPHRENIA, British Journal of Psychiatry, 172, 1998, pp. 90-92
Authors:
ADDINGTON J
ADDINGTON D
Citation: J. Addington et D. Addington, EFFECT OF SUBSTANCE MISUSE IN EARLY PSYCHOSIS, British Journal of Psychiatry, 172, 1998, pp. 134-136
Authors:
ADDINGTON J
ELGUEBALY N
CAMPBELL W
HODGINS DC
ADDINGTON D
Citation: J. Addington et al., SMOKING CESSATION TREATMENT FOR PATIENTS WITH SCHIZOPHRENIA, The American journal of psychiatry, 155(7), 1998, pp. 974-976
Authors:
BERNARD D
LANCON C
AUQUIER P
REINE G
ADDINGTON D
Citation: D. Bernard et al., CALGARY DEPRESSION SCALE FOR SCHIZOPHRENIA - A STUDY OF THE VALIDITY OF A FRENCH-LANGUAGE VERSION IN A POPULATION OF SCHIZOPHRENIC-PATIENTS, Acta psychiatrica Scandinavica, 97(1), 1998, pp. 36-41
Authors:
ADDINGTON J
ADDINGTON D
GASBARRE L
Citation: J. Addington et al., DISTRACTIBILITY AND SYMPTOMS IN SCHIZOPHRENIA, Journal of psychiatry & neuroscience, 22(3), 1997, pp. 180-184
Authors:
ADDINGTON J
ADDINGTON D
Citation: J. Addington et D. Addington, SUBSTANCE-ABUSE AND COGNITIVE-FUNCTIONING IN SCHIZOPHRENIA, Journal of psychiatry & neuroscience, 22(2), 1997, pp. 99-104
Authors:
ADDINGTON J
ADDINGTON D
Citation: J. Addington et D. Addington, NEUROCOGNITIVE AND SOCIAL FUNCTIONING IN SCHIZOPHRENIA - A 2.5 YEAR FOLLOW-UP-STUDY, Schizophrenia research, 24(1-2), 1997, pp. 95-95
Authors:
ADDINGTON J
ADDINGTON D
Citation: J. Addington et D. Addington, ATTENTIONAL VULNERABILITY INDICATORS IN SCHIZOPHRENIA AND BIPOLAR DISORDER, Schizophrenia research, 23(3), 1997, pp. 197-204
Authors:
ADDINGTON J
ADDINGTON D
Citation: J. Addington et D. Addington, NEUROCOGNITIVE FUNCTIONING IN SCHIZOPHRENIA - A TRIAL OF RISPERIDONE VERSUS HALOPERIDOL, Canadian journal of psychiatry, 42(9), 1997, pp. 983-983
Authors:
ADDINGTON D
WILLIAMS R
LAPIERRE Y
ELGUEBALY N
Citation: D. Addington et al., PLACEBOS IN CLINICAL-TRIALS FOR STUDYING PSYCHOTROPIC-DRUGS, Canadian journal of psychiatry, 42(5), 1997, pp. 4-9
Authors:
ADDINGTON D
WILLIAMS R
Citation: D. Addington et R. Williams, PLACEBOS IN CLINICAL-TRIALS OF PSYCHOTROPIC MEDICATION, Canadian journal of psychiatry, 42(3), 1997, pp. 5-10
Authors:
ADDINGTON J
ELGUEBALY N
ADDINGTON D
HODGINS D
Citation: J. Addington et al., READINESS TO STOP SMOKING IN SCHIZOPHRENIA, Canadian journal of psychiatry, 42(1), 1997, pp. 49-52
Authors:
ADDINGTON D
ADDINGTON J
PATTEN S
Citation: D. Addington et al., COURSE, CORRELATES AND PREDICTORS OF DEPRESSION IN SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, pp. 1-1
Authors:
ADDINGTON J
ADDINGTON D
Citation: J. Addington et D. Addington, COGNITIVE AND SOCIAL FUNCTIONING IN SCHIZOPHRENIA OUTPATIENTS WHO ABUSE SUBSTANCES, Schizophrenia research, 18(2-3), 1996, p.
Authors:
REMINGTON GJ
ADDINGTON D
COLLINS EJ
JONES BD
LALONDE P
MACCRIMMON DJ
Citation: Gj. Remington et al., CLOZAPINE - CURRENT STATUS AND ROLE IN THE PHARMACOTHERAPY OF SCHIZOPHRENIA (VOL 41, PG 161, 1996), Canadian journal of psychiatry, 41(7), 1996, pp. 483-483
Authors:
ADDINGTON D
ADDINGTON J
PATTEN S
Citation: D. Addington et al., GENDER AND AFFECT IN SCHIZOPHRENIA, Canadian journal of psychiatry, 41(5), 1996, pp. 265-268
Authors:
REMINGTON GJ
ADDINGTON D
COLLINS EJ
JONES BD
LALONDE P
MACCRIMMON DJ
MACEWAN GW
Citation: Gj. Remington et al., CLOZAPINE - CURRENT STATUS AND ROLE IN THE PHARMACOTHERAPY OF SCHIZOPHRENIA, Canadian journal of psychiatry, 41(3), 1996, pp. 161-166
Authors:
TOEWS J
LOCKYER J
ADDINGTON D
MCDOUGALL G
WARD R
SIMPSON E
Citation: J. Toews et al., IMPROVING THE MANAGEMENT OF PATIENTS WITH SCHIZOPHRENIA IN PRIMARY-CARE - ASSESSING LEARNING NEEDS AS A FIRST STEP, Canadian journal of psychiatry, 41(10), 1996, pp. 617-622
Authors:
ADDINGTON D
ADDINGTON J
ATKINSON M
Citation: D. Addington et al., FACTOR-ANALYSIS OF DEPRESSION SCALES IN SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 5-5
Authors:
ADDINGTON J
ADDINGTON D
Citation: J. Addington et D. Addington, COGNITIVE AND SOCIAL FUNCTIONING IN SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 107-107
Authors:
ADDINGTON D
Citation: D. Addington, THE USE OF PLACEBOS IN CLINICAL-TRIALS FOR ACUTE SCHIZOPHRENIA - REPLY, Canadian journal of psychiatry, 40(7), 1995, pp. 425-426